Spinal Cord Trial is Set to Resume After Vote

A potentially groundbreaking clinical trial to treat spinal cord injuries with tissue grown from human embryonic stem cells will resume, thanks to funding approved Thursday in San Diego by the state's stem cell agency.

http://ift.tt/1kQA0lD